These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 7903551)
41. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo. Moskophidis D; Pircher H; Ciernik I; Odermatt B; Hengartner H; Zinkernagel RM J Virol; 1992 Jun; 66(6):3661-8. PubMed ID: 1583725 [TBL] [Abstract][Full Text] [Related]
42. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. Jamieson BD; Ahmed R J Exp Med; 1989 Jun; 169(6):1993-2005. PubMed ID: 2471771 [TBL] [Abstract][Full Text] [Related]
43. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330 [TBL] [Abstract][Full Text] [Related]
44. An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. Chen L; Jay DC; Fairbanks JD; He X; Jensen PE J Immunol; 2011 Dec; 187(12):6463-72. PubMed ID: 22084437 [TBL] [Abstract][Full Text] [Related]
45. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. Gossmann J; Lohler J; Utermohlen O; Lehmann-Grube F Lab Invest; 1995 May; 72(5):559-70. PubMed ID: 7745950 [TBL] [Abstract][Full Text] [Related]
46. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930 [TBL] [Abstract][Full Text] [Related]
47. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338 [TBL] [Abstract][Full Text] [Related]
48. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae. Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286 [TBL] [Abstract][Full Text] [Related]
49. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion. Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703 [TBL] [Abstract][Full Text] [Related]
51. Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes. Mothé BR; Stewart BS; Oseroff C; Bui HH; Stogiera S; Garcia Z; Dow C; Rodriguez-Carreno MP; Kotturi M; Pasquetto V; Botten J; Crotty S; Janssen E; Buchmeier MJ; Sette A J Immunol; 2007 Jul; 179(2):1058-67. PubMed ID: 17617598 [TBL] [Abstract][Full Text] [Related]
52. MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice. Lehmann-Grube F; Dralle H; Utermöhlen O; Löhler J J Immunol; 1994 Jul; 153(2):595-603. PubMed ID: 8021497 [TBL] [Abstract][Full Text] [Related]
53. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy. Speiser DE; Miranda R; Zakarian A; Bachmann MF; McKall-Faienza K; Odermatt B; Hanahan D; Zinkernagel RM; Ohashi PS J Exp Med; 1997 Aug; 186(5):645-53. PubMed ID: 9271580 [TBL] [Abstract][Full Text] [Related]
54. Role of lymphotoxin alpha in T-cell responses during an acute viral infection. Suresh M; Lanier G; Large MK; Whitmire JK; Altman JD; Ruddle NH; Ahmed R J Virol; 2002 Apr; 76(8):3943-51. PubMed ID: 11907234 [TBL] [Abstract][Full Text] [Related]
55. Cutting edge: MHC class II-restricted killing in vivo during viral infection. Jellison ER; Kim SK; Welsh RM J Immunol; 2005 Jan; 174(2):614-8. PubMed ID: 15634878 [TBL] [Abstract][Full Text] [Related]
56. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344 [TBL] [Abstract][Full Text] [Related]
57. In vivo antiviral effect of cytotoxic T lymphocyte clones specific for lymphocytic choriomeningitis virus. Cihak J Microbiologica; 1986 Jul; 9(3):333-42. PubMed ID: 3489156 [TBL] [Abstract][Full Text] [Related]
58. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. Laufer TM; von Herrath MG; Grusby MJ; Oldstone MB; Glimcher LH J Exp Med; 1993 Aug; 178(2):589-96. PubMed ID: 8101862 [TBL] [Abstract][Full Text] [Related]
59. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Goossens PL; Milon G; Cossart P; Saron MF Int Immunol; 1995 May; 7(5):797-805. PubMed ID: 7547706 [TBL] [Abstract][Full Text] [Related]
60. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. Ehl S; Hombach J; Aichele P; Rülicke T; Odermatt B; Hengartner H; Zinkernagel R; Pircher H J Exp Med; 1998 Mar; 187(5):763-74. PubMed ID: 9480986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]